KCT0002826
招募中
未知
Pilot study of bone marrow-derived mesenchymal stem cells for the treatment of refractory hemorrhagic cystitis occurring after hematopoietic stem cell transplantation
The Catholic University of Korea, Seoul St. Mary's Hospital0 个研究点目标入组 3 人待定
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- The Catholic University of Korea, Seoul St. Mary's Hospital
- 入组人数
- 3
- 状态
- 招募中
- 最后更新
- 5年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •1\) Confirmed hemorrhagic cystitis patient occurring after allogeneic or autologous hematopoietic stem cell transplantation
- •2\) Patients with ECOG performance status rating of 0, 1, or 2
- •3\) Patients who are considered to be able to survive for 3 months or more
- •4\) Patients without evidence of acute infectious disease
- •5\) Patients who have no evidence of accompanying tumor
排除标准
- •1\) Pregnant, lactating women or women who have the possibiity of being pregnant or who have not taken adequate contraceptive
- •2\) Patients with active infection or fever with unknown etiology or ongoing bacterial or fungal infection
- •3\) ECOG performance status of 3 or 4
- •4\) Patients with previously confirmed HIV infection, uncontrolled hypertension (diastolic blood pressure \> 115mmg Hg), unstable angina, congestive heart failure (NY class II or higher), poorly controlled severe diabetes, coronary angioplasty within 6 months, Patients with acute myocardial infarction or non\-malignant disease including uncontrolled atrial or ventricular arrhythmia within the last 6 months
- •5\) Patients with mental illnesses,drug addiction, etc. who are judged to have an influence on the outcome of the study
- •6\) Patients participating in other clinical trials (but, subject to the clinical judgment of the investigator)
- •7\) Patients who are judged to be inadequate due to the judgment of the person in charge of clinical trial (principal investigator)
- •8\) Patients with other serious medical conditions that may reduce compliance with clinical trials
结局指标
主要结局
未指定
相似试验
已完成
1 期
Studying the effect of bone marrow mesenchymal stem cell injection into the subarachnoid space on improvement and reduction of complications in spinal cord injured patientsSpinal Cord Injury.Injury Of Spinal Cord, Level UnspecifiedIRCT2013050813267N1Shahid Sadoughi Yazd University Of Medical Sciences, Vice Chancellor for Research30
已完成
不适用
Clinical research of bone marrow-derived mesenchymal stem cell transplantation for the patients with epidermolysis bullosa.Epidermolysis bullosa (junctional, dystrophic)JPRN-UMIN000006723Osaka University Graduate School of Medicine6
已完成
不适用
Bone marrow derived mesenchymal stem cells for the treatment of allograft rejection after renal transplantatioaandoeningen na niertransplantatieallograft rejectionrejection after (renal) transplantation10038430NL-OMON31649eids Universitair Medisch Centrum15
已完成
不适用
Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients with Refractory Perianal Crohn*s DiseasefistulaM. Crohn10017969NL-OMON36386eids Universitair Medisch Centrum21
进行中（未招募）
不适用
Allogeneic Bone Marrow Derived Mesenchymal Stem Cellsfor the Treatment of Fistulas in Patients withRefractory Perianal Crohn’s Disease - allo bmMSCs CD fistulaEUCTR2009-015680-14-NLeiden University Medical Center